Rhodiola Rosea

Also known as: Golden root, Arctic root, Roseroot, Rosavins, Salidroside, SHR-5

Cognitive & NootropicGood evidence

An arctic adaptogen with a Scandinavian and Russian research history, studied for mental fatigue and stress resilience. Standardisation to rosavins and salidroside is what separates a working product from an inert one.

Typical dose

200.0–600.0 mg per day

Morning or early afternoon; avoid late in the day

What it is

Rhodiola rosea is a succulent perennial growing in cold, high-altitude regions across the Arctic, Scandinavia, Siberia and mountainous parts of Asia. The root has a long history of use in Scandinavian and Russian traditional practice, and was studied extensively by Soviet researchers interested in performance under stress.

Two compound groups matter: rosavins, which are relatively specific to R. rosea, and salidroside. Quality extracts are standardised to 3 per cent rosavins and 1 per cent salidroside, a 3:1 ratio chosen to match the naturally occurring proportion in the root.

Species substitution is a documented problem. Other Rhodiola species are cheaper and lack rosavins entirely, and adulteration has been repeatedly identified in market surveys. A product specifying R. rosea and declaring both rosavin and salidroside percentages is meaningfully different from one saying only Rhodiola extract.

How it works

Rhodiola is classified as an adaptogen, a term describing compounds proposed to increase resistance to stressors non-specifically. The most consistently proposed route is modulation of the hypothalamic-pituitary-adrenal axis and the stress hormone response.

It also appears to influence monoamine neurotransmitters, with reported inhibition of monoamine oxidase and effects on serotonin, dopamine and noradrenaline availability. This offers a plausible route for the mood and mental fatigue findings.

Effects on cellular energy metabolism have been described, including influence on ATP synthesis and on markers of oxidative stress in muscle. Salidroside in particular has been studied for cytoprotective effects under hypoxic conditions, consistent with the plant's high-altitude origin.

What the evidence shows

Mental fatigue is the best-supported outcome. Trials in shift workers, physicians on night duty, students during examination periods and military personnel have reported improvements in fatigue measures and cognitive performance under demanding conditions.

Research on burnout and stress-related fatigue has produced reasonably encouraging results, and there is a smaller body of work on depressive symptoms with mixed findings. Systematic reviews have generally described the evidence as promising but limited by methodological variability and small samples.

Physical performance evidence is weaker and inconsistent. Some trials report improved time to exhaustion, others find nothing. The pattern across the literature is that Rhodiola performs best where fatigue is the limiting factor, which fits the mechanism better than a general ergogenic claim would.

Dosing

Typical range is 200-600 mg daily of extract standardised to 3 per cent rosavins and 1 per cent salidroside. Most trials used doses within this band. Unlike many adaptogens, Rhodiola appears to have acute effects as well as cumulative ones, with some trials reporting benefits from single doses under acute stress. Take in the morning or early afternoon. It can be stimulating enough to interfere with sleep if taken late, which is the most common complaint from new users. Take on an empty stomach or before food, and be wary of any product that does not declare both marker compounds.

At a glance

Common forms3% rosavins / 1% salidroside extract, SHR-5 extract, High-salidroside extract, Whole root powder
Half-life / durationEffects reported acutely and cumulatively; salidroside clears within hours
TimingMorning or early afternoon; avoid late in the day
Competition statusPermitted — not on the WADA Prohibited List
CategoryCognitive & Nootropic

Safety and side effects

Generally well tolerated across the trial literature. The most frequently reported effects are dizziness, dry mouth and, notably, over-stimulation or restlessness, particularly at higher doses or when taken later in the day.

Rhodiola has an activating profile, and anyone taking regular medication that acts on mood or the nervous system should seek advice before use rather than adding it on top.

Long-term safety data beyond the durations used in trials is limited.

Who should avoid it

Speak to your doctor before use if you take regular medication, particularly anything acting on mood or the nervous system. Take care if your blood pressure is being managed, or alongside stimulants. Not established for use in pregnancy or breastfeeding. Avoid taking late in the day if prone to sleep disturbance.

Products containing Rhodiola Rosea

This entry is provided for information only. Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Consult a qualified healthcare professional before use if you are pregnant, breastfeeding, taking medication or under medical supervision.